By Bhanvi Satija and Christy Santhosh (Reuters) -Websites selling compounded versions of popular weight-loss drugs from Novo ...

Eli Lilly unexpectedly lowered its full-year 2024 guidance. The miss appears to stem from a lack of the typical December ...

Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...

Current laws and regulations are not enough to protect Americans from the risks of compounded versions of popular weight loss ...

A recent study reveals many websites selling compounded versions of weight-loss drugs do not inform users of risks, often ...

Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

A Bucks County woman is speaking out after her insurance company decided to no longer cover weight loss drugs.

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

Global health highlights include a court pausing a generic version of a heart drug, Novo Nordisk's weight loss trial success, ...